

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 8.94013967 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.59674909 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 8.57170382 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.67965869 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.67965869 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.34924369 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.34924369 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.88169870 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.18362848 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.18362848 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.18362848 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.05107246 |
| 13 | * triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.01445425 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.98999324 |
| 15 | drug metabolic process (GO:0017144) | 5.95057866 |
| 16 | regulation of plasminogen activation (GO:0010755) | 5.87551354 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.82289434 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.78752788 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.77938495 |
| 20 | urea cycle (GO:0000050) | 5.74996762 |
| 21 | urea metabolic process (GO:0019627) | 5.74996762 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.70670444 |
| 23 | oxidative demethylation (GO:0070989) | 5.69486469 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.62788190 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.42053709 |
| 26 | protein carboxylation (GO:0018214) | 5.40261608 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.40261608 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 5.35899749 |
| 29 | cysteine metabolic process (GO:0006534) | 5.32708857 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.28884845 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.27900042 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.27226982 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.16553842 |
| 34 | acute-phase response (GO:0006953) | 5.13972358 |
| 35 | bile acid metabolic process (GO:0008206) | 5.13826929 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 5.03587928 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.00369710 |
| 38 | regulation of humoral immune response (GO:0002920) | 4.98460801 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.97086086 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92972190 |
| 41 | regulation of complement activation (GO:0030449) | 4.90284064 |
| 42 | ethanol metabolic process (GO:0006067) | 4.89466775 |
| 43 | tyrosine metabolic process (GO:0006570) | 4.89030165 |
| 44 | negative regulation of protein activation cascade (GO:2000258) | 4.84160321 |
| 45 | phenylpropanoid metabolic process (GO:0009698) | 4.83984062 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.81340868 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.81340868 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.75919506 |
| 49 | phospholipid efflux (GO:0033700) | 4.73364063 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.70949009 |
| 51 | negative regulation of sterol transport (GO:0032372) | 4.70949009 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.68490898 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.64744189 |
| 54 | * protein-lipid complex remodeling (GO:0034368) | 4.61370617 |
| 55 | * macromolecular complex remodeling (GO:0034367) | 4.61370617 |
| 56 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.61370617 |
| 57 | lysine catabolic process (GO:0006554) | 4.57984084 |
| 58 | lysine metabolic process (GO:0006553) | 4.57984084 |
| 59 | S-adenosylmethionine metabolic process (GO:0046500) | 4.55001858 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.53311691 |
| 61 | * triglyceride homeostasis (GO:0070328) | 4.46841443 |
| 62 | * acylglycerol homeostasis (GO:0055090) | 4.46841443 |
| 63 | plasma lipoprotein particle clearance (GO:0034381) | 4.45518562 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.45035155 |
| 65 | glycine metabolic process (GO:0006544) | 4.42810612 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.41991021 |
| 67 | * regulation of triglyceride catabolic process (GO:0010896) | 4.40952838 |
| 68 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.39756740 |
| 69 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.39756740 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.38467468 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.38273609 |
| 72 | negative regulation of coagulation (GO:0050819) | 4.37067026 |
| 73 | positive regulation of blood coagulation (GO:0030194) | 4.36932465 |
| 74 | positive regulation of hemostasis (GO:1900048) | 4.36932465 |
| 75 | negative regulation of wound healing (GO:0061045) | 4.32396533 |
| 76 | cholesterol efflux (GO:0033344) | 4.30935980 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.30101412 |
| 78 | amine catabolic process (GO:0009310) | 4.29294460 |
| 79 | cellular biogenic amine catabolic process (GO:0042402) | 4.29294460 |
| 80 | cellular glucuronidation (GO:0052695) | 4.28312757 |
| 81 | glutamate metabolic process (GO:0006536) | 4.27835548 |
| 82 | alkaloid metabolic process (GO:0009820) | 4.25875770 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 4.18322667 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.14409121 |
| 85 | intestinal cholesterol absorption (GO:0030299) | 4.09169027 |
| 86 | arginine metabolic process (GO:0006525) | 4.09016147 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 4.07561350 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07495978 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.06723405 |
| 90 | ethanol oxidation (GO:0006069) | 4.06516547 |
| 91 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05310550 |
| 92 | fibrinolysis (GO:0042730) | 4.02488642 |
| 93 | aldehyde catabolic process (GO:0046185) | 4.02023200 |
| 94 | negative regulation of complement activation (GO:0045916) | 4.01825770 |
| 95 | drug catabolic process (GO:0042737) | 4.00925623 |
| 96 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.00748361 |
| 97 | positive regulation of coagulation (GO:0050820) | 4.00303820 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 4.00089906 |
| 99 | regulation of apoptotic cell clearance (GO:2000425) | 3.97083135 |
| 100 | ketone body metabolic process (GO:1902224) | 3.92504148 |
| 101 | negative regulation of lipase activity (GO:0060192) | 3.88244615 |
| 102 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86127025 |
| 103 | acute inflammatory response (GO:0002526) | 3.85214686 |
| 104 | cofactor catabolic process (GO:0051187) | 3.84048843 |
| 105 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80906847 |
| 106 | glucuronate metabolic process (GO:0019585) | 3.80060481 |
| 107 | uronic acid metabolic process (GO:0006063) | 3.80060481 |
| 108 | organic acid catabolic process (GO:0016054) | 3.77336699 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.77336699 |
| 110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76829538 |
| 111 | phospholipid homeostasis (GO:0055091) | 3.74877662 |
| 112 | complement activation, classical pathway (GO:0006958) | 3.73844237 |
| 113 | protein activation cascade (GO:0072376) | 3.70564093 |
| 114 | complement activation (GO:0006956) | 3.70168111 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.69247951 |
| 116 | short-chain fatty acid metabolic process (GO:0046459) | 3.67209991 |
| 117 | regulation of cholesterol homeostasis (GO:2000188) | 3.66570378 |
| 118 | * cholesterol homeostasis (GO:0042632) | 3.66098615 |
| 119 | protein-lipid complex assembly (GO:0065005) | 3.64913181 |
| 120 | cytolysis (GO:0019835) | 3.60162101 |
| 121 | * sterol homeostasis (GO:0055092) | 3.59867409 |
| 122 | NAD biosynthetic process (GO:0009435) | 3.59227269 |
| 123 | opsonization (GO:0008228) | 3.56523044 |
| 124 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55975388 |
| 125 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55975388 |
| 126 | flavonoid metabolic process (GO:0009812) | 3.53077697 |
| 127 | proline metabolic process (GO:0006560) | 3.52327888 |
| 128 | response to mercury ion (GO:0046689) | 3.51865491 |
| 129 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.51394528 |
| 130 | regulation of acute inflammatory response (GO:0002673) | 3.49301073 |
| 131 | hormone catabolic process (GO:0042447) | 3.44196740 |
| 132 | regulation of lipoprotein particle clearance (GO:0010984) | 3.41250593 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.44642631 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22415673 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.00396683 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50760365 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.23269308 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.14014267 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.88833763 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04322481 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01600224 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07604836 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0168283 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98970198 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.97373230 |
| 14 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59488935 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.55985432 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55686926 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44423028 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39977838 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31415168 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23811256 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19909766 |
| 22 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19710305 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17603978 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.15672245 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05302332 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00908112 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00385387 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93422684 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90373856 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89732460 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85374820 |
| 32 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84612849 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83399993 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.82529635 |
| 35 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.79865021 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78476729 |
| 37 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78296072 |
| 38 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77745104 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76298995 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76076344 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.75509989 |
| 42 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74688752 |
| 43 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73609199 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.72185700 |
| 45 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71391016 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71194415 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70580896 |
| 48 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.70459368 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70385099 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69968536 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66554408 |
| 52 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.66553732 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65726393 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65634566 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.64977071 |
| 56 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64785154 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64652775 |
| 58 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63347692 |
| 59 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63347692 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63231823 |
| 61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63127990 |
| 62 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63118892 |
| 63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.63077401 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61739018 |
| 65 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61210545 |
| 66 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60592643 |
| 67 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.58760898 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.58756143 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.58430716 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.57598736 |
| 71 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57331794 |
| 72 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56993874 |
| 73 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56783946 |
| 74 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.56303822 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55449375 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.55341140 |
| 77 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.55048031 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54861571 |
| 79 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.54844473 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.54259479 |
| 81 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.54246768 |
| 82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.53816161 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.53323637 |
| 84 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52827299 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.52533052 |
| 86 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52372620 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51830767 |
| 88 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51729791 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51010897 |
| 90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50886536 |
| 91 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.50414234 |
| 92 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50408657 |
| 93 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.49406739 |
| 94 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.49262408 |
| 95 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49171755 |
| 96 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49096641 |
| 97 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.48738001 |
| 98 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48263408 |
| 99 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.48152725 |
| 100 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47743768 |
| 101 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.47426676 |
| 102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46768014 |
| 103 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.46604804 |
| 104 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46515465 |
| 105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46194446 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.45894594 |
| 107 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.45809669 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44361785 |
| 109 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43568721 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.42748682 |
| 111 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42605652 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42332864 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41202918 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.41200328 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41183950 |
| 116 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40119014 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.40063889 |
| 118 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.39861416 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.39403396 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38944049 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38691872 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38660702 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38443827 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38441394 |
| 125 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38108105 |
| 126 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38032554 |
| 127 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37181686 |
| 128 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37118550 |
| 129 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35926834 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34860780 |
| 131 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34513810 |
| 132 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.34079327 |
| 133 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34010192 |
| 134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.33454740 |
| 135 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.33004449 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.32436975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.37958126 |
| 2 | MP0005360_urolithiasis | 7.45229238 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.47870869 |
| 4 | MP0005365_abnormal_bile_salt | 6.20458479 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.20571346 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.22582583 |
| 7 | MP0003252_abnormal_bile_duct | 3.93391216 |
| 8 | * MP0010329_abnormal_lipoprotein_level | 3.49728284 |
| 9 | MP0009840_abnormal_foam_cell | 3.39318070 |
| 10 | MP0005083_abnormal_biliary_tract | 3.11453794 |
| 11 | MP0003195_calcinosis | 2.83674474 |
| 12 | MP0005332_abnormal_amino_acid | 2.76213024 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59121825 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.35758445 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17784735 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13571949 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.09444194 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.98750478 |
| 19 | MP0003868_abnormal_feces_composition | 1.94347906 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82770338 |
| 21 | MP0001764_abnormal_homeostasis | 1.66415374 |
| 22 | MP0009697_abnormal_copulation | 1.59084727 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56374828 |
| 24 | MP0005451_abnormal_body_composition | 1.53763306 |
| 25 | MP0003011_delayed_dark_adaptation | 1.39087933 |
| 26 | MP0002132_abnormal_respiratory_system | 1.28376223 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.25814802 |
| 28 | MP0003186_abnormal_redox_activity | 1.25547541 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.20974933 |
| 30 | MP0000598_abnormal_liver_morphology | 1.17965011 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.14131579 |
| 32 | MP0005647_abnormal_sex_gland | 1.13184794 |
| 33 | MP0000604_amyloidosis | 1.10198050 |
| 34 | MP0009764_decreased_sensitivity_to | 1.06097863 |
| 35 | MP0001915_intracranial_hemorrhage | 1.02716676 |
| 36 | MP0009763_increased_sensitivity_to | 1.01880277 |
| 37 | MP0002254_reproductive_system_inflammat | 1.00378490 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.93230633 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90512783 |
| 40 | MP0008469_abnormal_protein_level | 0.88381249 |
| 41 | MP0002282_abnormal_trachea_morphology | 0.87041077 |
| 42 | * MP0009642_abnormal_blood_homeostasis | 0.86108396 |
| 43 | MP0005670_abnormal_white_adipose | 0.84103783 |
| 44 | MP0005408_hypopigmentation | 0.82283786 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 0.81951908 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.79686499 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.78476019 |
| 48 | MP0002078_abnormal_glucose_homeostasis | 0.78327502 |
| 49 | MP0000566_synostosis | 0.77839637 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.76850723 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 0.76696695 |
| 52 | MP0003879_abnormal_hair_cell | 0.74822224 |
| 53 | MP0002249_abnormal_larynx_morphology | 0.73549539 |
| 54 | MP0002971_abnormal_brown_adipose | 0.73438244 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.70740627 |
| 56 | MP0005187_abnormal_penis_morphology | 0.70513891 |
| 57 | MP0005334_abnormal_fat_pad | 0.69849671 |
| 58 | MP0004130_abnormal_muscle_cell | 0.69181144 |
| 59 | MP0003690_abnormal_glial_cell | 0.68798549 |
| 60 | MP0005535_abnormal_body_temperature | 0.66848520 |
| 61 | MP0005266_abnormal_metabolism | 0.65089570 |
| 62 | MP0001661_extended_life_span | 0.64857886 |
| 63 | MP0009053_abnormal_anal_canal | 0.64593002 |
| 64 | MP0003329_amyloid_beta_deposits | 0.64178525 |
| 65 | MP0000639_abnormal_adrenal_gland | 0.61111990 |
| 66 | MP0001756_abnormal_urination | 0.58238634 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 0.57171464 |
| 68 | MP0005448_abnormal_energy_balance | 0.55908331 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.53496502 |
| 70 | MP0002822_catalepsy | 0.51684877 |
| 71 | MP0005395_other_phenotype | 0.48600702 |
| 72 | MP0008874_decreased_physiological_sensi | 0.46859006 |
| 73 | MP0003638_abnormal_response/metabolism_ | 0.46745661 |
| 74 | MP0002928_abnormal_bile_duct | 0.46119109 |
| 75 | MP0009785_altered_susceptibility_to | 0.45972668 |
| 76 | MP0003718_maternal_effect | 0.45781794 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.45117117 |
| 78 | MP0008873_increased_physiological_sensi | 0.45037728 |
| 79 | MP0005023_abnormal_wound_healing | 0.44243678 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.44196514 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 0.42815915 |
| 82 | MP0003724_increased_susceptibility_to | 0.42250853 |
| 83 | MP0003436_decreased_susceptibility_to | 0.42223825 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.41811147 |
| 85 | MP0003075_altered_response_to | 0.40828446 |
| 86 | MP0003953_abnormal_hormone_level | 0.40632624 |
| 87 | MP0005248_abnormal_Harderian_gland | 0.40339846 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.38703638 |
| 89 | MP0008872_abnormal_physiological_respon | 0.38411024 |
| 90 | MP0005166_decreased_susceptibility_to | 0.37150575 |
| 91 | MP0004381_abnormal_hair_follicle | 0.36836189 |
| 92 | MP0009672_abnormal_birth_weight | 0.35560387 |
| 93 | MP0000579_abnormal_nail_morphology | 0.33961123 |
| 94 | MP0009115_abnormal_fat_cell | 0.33124271 |
| 95 | MP0001243_abnormal_dermal_layer | 0.32781020 |
| 96 | MP0003172_abnormal_lysosome_physiology | 0.32687510 |
| 97 | MP0000249_abnormal_blood_vessel | 0.32498782 |
| 98 | MP0006082_CNS_inflammation | 0.31915228 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.31890087 |
| 100 | MP0004883_abnormal_blood_vessel | 0.31871995 |
| 101 | MP0002796_impaired_skin_barrier | 0.31607044 |
| 102 | MP0002970_abnormal_white_adipose | 0.31366338 |
| 103 | MP0002168_other_aberrant_phenotype | 0.30957939 |
| 104 | MP0001853_heart_inflammation | 0.30785280 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.30109811 |
| 106 | MP0009384_cardiac_valve_regurgitation | 0.29315896 |
| 107 | MP0006292_abnormal_olfactory_placode | 0.28677172 |
| 108 | MP0001881_abnormal_mammary_gland | 0.27933653 |
| 109 | MP0001845_abnormal_inflammatory_respons | 0.27612732 |
| 110 | MP0002090_abnormal_vision | 0.25109713 |
| 111 | MP0005164_abnormal_response_to | 0.24827180 |
| 112 | MP0002060_abnormal_skin_morphology | 0.23727707 |
| 113 | MP0003122_maternal_imprinting | 0.23342124 |
| 114 | MP0004272_abnormal_basement_membrane | 0.22653101 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.21682737 |
| 116 | MP0002128_abnormal_blood_circulation | 0.21120392 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.19567716 |
| 118 | MP0001851_eye_inflammation | 0.19203156 |
| 119 | MP0003878_abnormal_ear_physiology | 0.18379793 |
| 120 | MP0005377_hearing/vestibular/ear_phenot | 0.18379793 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.18054671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.58350082 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.50689640 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.28657549 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.84250076 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.63086327 |
| 6 | Xanthomatosis (HP:0000991) | 6.42363271 |
| 7 | * Hypobetalipoproteinemia (HP:0003563) | 5.77185731 |
| 8 | Complement deficiency (HP:0004431) | 5.27653940 |
| 9 | * Hyperlipoproteinemia (HP:0010980) | 4.86876260 |
| 10 | Joint hemorrhage (HP:0005261) | 4.84129151 |
| 11 | Hyperammonemia (HP:0001987) | 4.67807202 |
| 12 | Epidermoid cyst (HP:0200040) | 4.60618349 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50716190 |
| 14 | * Hypolipoproteinemia (HP:0010981) | 4.45220373 |
| 15 | Hyperglycinemia (HP:0002154) | 4.43606742 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.41946952 |
| 17 | Ketosis (HP:0001946) | 4.33061482 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31097559 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22009077 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15117940 |
| 21 | Fat malabsorption (HP:0002630) | 4.11448518 |
| 22 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10937272 |
| 23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.94761216 |
| 24 | Hyperglycinuria (HP:0003108) | 3.91819358 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.91264323 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.91199816 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.91199816 |
| 28 | Abnormality of complement system (HP:0005339) | 3.85005372 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77782988 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70065299 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.68997381 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44601723 |
| 33 | * Hypoalphalipoproteinemia (HP:0003233) | 3.42580650 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39813397 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.37555781 |
| 36 | Spontaneous abortion (HP:0005268) | 3.12850521 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.11732941 |
| 38 | Steatorrhea (HP:0002570) | 3.11221990 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10987274 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.10959877 |
| 41 | Ketoacidosis (HP:0001993) | 3.04613178 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.01032726 |
| 43 | Myocardial infarction (HP:0001658) | 2.97670879 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.97124640 |
| 45 | Skin nodule (HP:0200036) | 2.83918707 |
| 46 | Metabolic acidosis (HP:0001942) | 2.79947192 |
| 47 | Purpura (HP:0000979) | 2.76199850 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.69836619 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.69100303 |
| 50 | Lethargy (HP:0001254) | 2.63908326 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.61118655 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.61118655 |
| 53 | Vascular calcification (HP:0004934) | 2.60170866 |
| 54 | Acanthocytosis (HP:0001927) | 2.51895435 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.51498019 |
| 56 | Spastic diplegia (HP:0001264) | 2.51270378 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.49184493 |
| 58 | Pulmonary embolism (HP:0002204) | 2.48783970 |
| 59 | Gout (HP:0001997) | 2.47106563 |
| 60 | Mitral stenosis (HP:0001718) | 2.46177737 |
| 61 | Cerebral edema (HP:0002181) | 2.45601635 |
| 62 | Glomerulonephritis (HP:0000099) | 2.44607619 |
| 63 | Cholelithiasis (HP:0001081) | 2.43478160 |
| 64 | Osteomalacia (HP:0002749) | 2.42049008 |
| 65 | Abnormal gallbladder physiology (HP:0012438) | 2.41182527 |
| 66 | Cholecystitis (HP:0001082) | 2.41182527 |
| 67 | Neonatal hypoglycemia (HP:0001998) | 2.39769802 |
| 68 | Irritability (HP:0000737) | 2.39536156 |
| 69 | Amyloidosis (HP:0011034) | 2.38598807 |
| 70 | Neonatal onset (HP:0003623) | 2.36326847 |
| 71 | Fair hair (HP:0002286) | 2.32511691 |
| 72 | Malnutrition (HP:0004395) | 2.30870972 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.30654898 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27572096 |
| 75 | Gingival bleeding (HP:0000225) | 2.26869603 |
| 76 | Reduced antithrombin III activity (HP:0001976) | 2.21462388 |
| 77 | Brushfield spots (HP:0001088) | 2.20377425 |
| 78 | Esophageal varix (HP:0002040) | 2.19361137 |
| 79 | Menorrhagia (HP:0000132) | 2.17857211 |
| 80 | Late onset (HP:0003584) | 2.17020373 |
| 81 | Pancreatitis (HP:0001733) | 2.16057977 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.15813592 |
| 83 | Enlarged kidneys (HP:0000105) | 2.14055622 |
| 84 | Thrombophlebitis (HP:0004418) | 2.12479002 |
| 85 | Vomiting (HP:0002013) | 2.09337122 |
| 86 | Arthropathy (HP:0003040) | 2.05847620 |
| 87 | Abnormality of the Achilles tendon (HP:0005109) | 2.05010623 |
| 88 | Opisthotonus (HP:0002179) | 2.04789596 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04277782 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.03515953 |
| 91 | Hemorrhage of the eye (HP:0011885) | 2.02416726 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 2.02092052 |
| 93 | Elevated alkaline phosphatase (HP:0003155) | 2.01770550 |
| 94 | Poikilocytosis (HP:0004447) | 2.01595926 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.96115586 |
| 96 | Rickets (HP:0002748) | 1.95759542 |
| 97 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91599122 |
| 98 | Gangrene (HP:0100758) | 1.91593193 |
| 99 | Increased serum ferritin (HP:0003281) | 1.91068774 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.89610270 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.88619185 |
| 102 | Renal cortical cysts (HP:0000803) | 1.87955976 |
| 103 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.87729527 |
| 104 | Epistaxis (HP:0000421) | 1.86605793 |
| 105 | Hydroxyprolinuria (HP:0003080) | 1.84296763 |
| 106 | Abnormality of proline metabolism (HP:0010907) | 1.84296763 |
| 107 | Elevated hepatic transaminases (HP:0002910) | 1.83398967 |
| 108 | Status epilepticus (HP:0002133) | 1.83316489 |
| 109 | Alkalosis (HP:0001948) | 1.82845884 |
| 110 | Joint swelling (HP:0001386) | 1.79578063 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.78285435 |
| 112 | Hyperglycemia (HP:0003074) | 1.76523389 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.75497381 |
| 114 | Increased serum pyruvate (HP:0003542) | 1.74727398 |
| 115 | Nephritis (HP:0000123) | 1.73823644 |
| 116 | Bifid scrotum (HP:0000048) | 1.70665556 |
| 117 | Hyperphosphaturia (HP:0003109) | 1.66031153 |
| 118 | Increased mean platelet volume (HP:0011877) | 1.64244456 |
| 119 | Atrioventricular block (HP:0001678) | 1.58271454 |
| 120 | Reticulocytosis (HP:0001923) | 1.56645438 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 1.56491266 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 1.53316153 |
| 123 | Bile duct proliferation (HP:0001408) | 1.53316153 |
| 124 | Abnormal platelet function (HP:0011869) | 1.52415893 |
| 125 | Impaired platelet aggregation (HP:0003540) | 1.52415893 |
| 126 | Abnormality of glycolysis (HP:0004366) | 1.51154367 |
| 127 | Abnormality of urine glucose concentration (HP:0011016) | 1.49861433 |
| 128 | Glycosuria (HP:0003076) | 1.49861433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.24663015 |
| 2 | SIK1 | 4.63155346 |
| 3 | FGFR4 | 4.60714987 |
| 4 | ERN1 | 4.44515902 |
| 5 | TAOK3 | 3.03102866 |
| 6 | INSRR | 2.95436279 |
| 7 | ERBB4 | 2.88242362 |
| 8 | MAP2K4 | 2.38070985 |
| 9 | PKN2 | 2.31374411 |
| 10 | MST1R | 2.02577806 |
| 11 | FLT3 | 1.95539486 |
| 12 | MAPK11 | 1.86101555 |
| 13 | PIK3CG | 1.79145702 |
| 14 | TRIB3 | 1.76748471 |
| 15 | TYK2 | 1.67831577 |
| 16 | NTRK3 | 1.63190286 |
| 17 | LATS1 | 1.60239484 |
| 18 | DAPK2 | 1.55714213 |
| 19 | ABL2 | 1.50909095 |
| 20 | PTK6 | 1.45193716 |
| 21 | FGFR2 | 1.37530287 |
| 22 | NEK9 | 1.35933233 |
| 23 | KDR | 1.34487542 |
| 24 | FRK | 1.32086409 |
| 25 | PRPF4B | 1.27311833 |
| 26 | JAK2 | 1.22327523 |
| 27 | PINK1 | 1.18675727 |
| 28 | MAP3K7 | 1.18055039 |
| 29 | PRKAA2 | 1.12813828 |
| 30 | MAP2K3 | 1.08529473 |
| 31 | GRK6 | 1.08193385 |
| 32 | TBK1 | 1.07328097 |
| 33 | JAK1 | 1.01503034 |
| 34 | MAPK4 | 1.01210991 |
| 35 | ERBB2 | 1.00594917 |
| 36 | AKT3 | 1.00108605 |
| 37 | MAP3K14 | 0.98355100 |
| 38 | PDK2 | 0.97887302 |
| 39 | NLK | 0.96527739 |
| 40 | MAP3K10 | 0.95712179 |
| 41 | PRKCZ | 0.92668929 |
| 42 | MAPK15 | 0.91604108 |
| 43 | PDGFRA | 0.89593177 |
| 44 | PRKG1 | 0.88906938 |
| 45 | CDK12 | 0.86746391 |
| 46 | MAP3K3 | 0.86609025 |
| 47 | WNK4 | 0.85351133 |
| 48 | EPHB1 | 0.83458757 |
| 49 | MAPK12 | 0.83198007 |
| 50 | STK38L | 0.82420484 |
| 51 | CDK6 | 0.81516999 |
| 52 | MET | 0.80328627 |
| 53 | SMG1 | 0.79951324 |
| 54 | SGK1 | 0.79607291 |
| 55 | MAP3K11 | 0.79113316 |
| 56 | TIE1 | 0.77546032 |
| 57 | PRKACG | 0.76652336 |
| 58 | TNK2 | 0.76363790 |
| 59 | EPHA3 | 0.75487240 |
| 60 | CAMK2G | 0.73122624 |
| 61 | CSK | 0.72709448 |
| 62 | DYRK1B | 0.71794925 |
| 63 | MAP2K6 | 0.70585682 |
| 64 | PRKACA | 0.69622542 |
| 65 | MAP3K2 | 0.69352692 |
| 66 | CAMK1D | 0.69351837 |
| 67 | FGFR1 | 0.68826576 |
| 68 | GSK3A | 0.67611758 |
| 69 | FER | 0.65108482 |
| 70 | PRKAA1 | 0.64485404 |
| 71 | STK38 | 0.64005480 |
| 72 | IRAK3 | 0.63949438 |
| 73 | SGK3 | 0.63567224 |
| 74 | RIPK1 | 0.60740989 |
| 75 | MAPK7 | 0.59824116 |
| 76 | CSNK1D | 0.59237148 |
| 77 | TGFBR2 | 0.59188392 |
| 78 | FGFR3 | 0.56178538 |
| 79 | CSF1R | 0.55723492 |
| 80 | IKBKE | 0.54844939 |
| 81 | RPS6KA3 | 0.53979852 |
| 82 | PTK2 | 0.53645118 |
| 83 | EPHA4 | 0.52651645 |
| 84 | PDPK1 | 0.52400381 |
| 85 | CSNK1G1 | 0.52252266 |
| 86 | CSNK1E | 0.51910282 |
| 87 | PRKCQ | 0.51698544 |
| 88 | CAMKK1 | 0.48665372 |
| 89 | TAOK2 | 0.48349506 |
| 90 | PRKCB | 0.46484846 |
| 91 | SGK2 | 0.46112686 |
| 92 | SRC | 0.45216333 |
| 93 | GRK1 | 0.44624765 |
| 94 | MAP3K5 | 0.44363798 |
| 95 | IGF1R | 0.43224113 |
| 96 | MAP3K13 | 0.43209586 |
| 97 | RET | 0.42523818 |
| 98 | MAP2K1 | 0.41732304 |
| 99 | CDK4 | 0.41392355 |
| 100 | ZAP70 | 0.40969591 |
| 101 | SIK2 | 0.40865783 |
| 102 | PRKCG | 0.40684378 |
| 103 | CSNK2A1 | 0.39942325 |
| 104 | PKN1 | 0.39237862 |
| 105 | CAMKK2 | 0.38875639 |
| 106 | MAPKAPK3 | 0.38840171 |
| 107 | CSNK2A2 | 0.38338363 |
| 108 | ICK | 0.38245205 |
| 109 | PRKACB | 0.37487209 |
| 110 | MAP3K6 | 0.37024017 |
| 111 | MAPK3 | 0.35766239 |
| 112 | CAMK4 | 0.34835968 |
| 113 | MTOR | 0.34387776 |
| 114 | CSNK1G2 | 0.32817316 |
| 115 | PDK1 | 0.32616036 |
| 116 | PBK | 0.32500747 |
| 117 | EGFR | 0.32335319 |
| 118 | SGK223 | 0.31154594 |
| 119 | SGK494 | 0.31154594 |
| 120 | AKT2 | 0.30737388 |
| 121 | CSNK1G3 | 0.30524877 |
| 122 | EEF2K | 0.29687181 |
| 123 | MAPK10 | 0.28596865 |
| 124 | RPS6KB1 | 0.27710452 |
| 125 | MAP3K1 | 0.27680464 |
| 126 | LATS2 | 0.27278303 |
| 127 | IRAK2 | 0.26322692 |
| 128 | PRKCA | 0.25885892 |
| 129 | IRAK1 | 0.24638149 |
| 130 | CAMK1G | 0.23403431 |
| 131 | CSNK1A1L | 0.22007050 |
| 132 | PIK3CA | 0.21430554 |
| 133 | ABL1 | 0.21052673 |
| 134 | PDK3 | 0.20651881 |
| 135 | PDK4 | 0.20651881 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52598503 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55789963 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.41727638 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37024378 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.09356084 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77967235 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74101796 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68838505 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61052251 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53591086 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50097211 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37614089 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26302211 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14757333 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14403887 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09535372 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96405984 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.93910878 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93068000 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.91430207 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.90368213 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82880450 |
| 23 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81411939 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78103090 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75251973 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74868130 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74817308 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71754732 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71014818 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66845272 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61831096 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56867543 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56811215 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51502294 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51270146 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.49372830 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43993019 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36974124 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36356594 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33548082 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32174174 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27953026 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21940362 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20665219 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19172785 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16351346 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16215148 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12135254 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04110418 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01588641 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97964038 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97559257 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96424798 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94577361 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92086408 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87247981 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84396948 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84282805 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81332319 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75045601 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69888041 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67782511 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63931115 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56627846 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54025174 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46487567 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45771786 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42597317 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.42398835 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.33866967 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26448088 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25403153 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23655682 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23397395 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22563357 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22226208 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21456113 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18564831 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16468213 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10966922 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02494040 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2579730 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2546743 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2505750 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | -0.2464462 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2409315 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2407345 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2358424 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2242046 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2062307 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1995261 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1979241 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1939269 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1832131 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1776308 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1665764 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1655046 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1600553 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1591164 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1546602 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1401082 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1396243 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1386024 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0979233 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0940272 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0783262 |
| 107 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0763608 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0688489 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0381391 |
| 110 | Mineral absorption_Homo sapiens_hsa04978 | -0.0064860 |

